Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumorsJian Li, Lin Shen, Yanhong Deng et al.|Journal of Hematology & Oncology|2021Cited by 149
EZH2-mediated epigenetic suppression of lncRNA PCAT18 predicts a poor prognosis and regulates the expression of p16 by interacting with miR-570a-3p in gastric cancerLiangjun Zhu, Wei De|Journal of Cancer|2021Cited by 17
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, observational, non-interventional phase IV trialFeng‐Hua Wang, Rui‐Hua Xu, Guanghai Dai et al.|Chinese Journal of Cancer Research|2021Cited by 11
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in ChinaWang Qu, Aiping Zhou, Liangjun Zhu et al.|BMC Cancer|2024Cited by 10
Treatment modalities of regorafenib and survival in metastatic colorectal (mCRC) patients: A real-world multicenter retrospective study.Wang Qu, Aiping Zhou, Zimin Liu et al.|Journal of Clinical Oncology|2023Cited by 1